These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16955198)

  • 1. Severe exacerbation of psoriatic arthritis during treatment with efalizumab. A case report.
    Bang B; Gniadecki R
    Acta Derm Venereol; 2006; 86(5):456-7. PubMed ID: 16955198
    [No Abstract]   [Full Text] [Related]  

  • 2. New-onset, debilitating arthritis in psoriasis patients receiving efalizumab.
    Myers WA; Najarian D; Gottlieb AB
    J Dermatolog Treat; 2006; 17(6):353-4. PubMed ID: 17853308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis.
    Viguier M; Richette P; Aubin F; Beylot-Barry M; Lahfa M; Bedane C; Delesalle F; Richard-Lallemand MA; Delaporte E; Dubertret L; Bardin T; Bachelez H
    Arthritis Rheum; 2008 Jun; 58(6):1796-802. PubMed ID: 18512820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed generalized inflammatory psoriasis flare during efalizumab treatment.
    Martin B; Sánchez-Carazo JL; Pérez-Ferriols A; Oliver V; Alegre V
    Br J Dermatol; 2009 Jul; 161(1):212-3. PubMed ID: 19438856
    [No Abstract]   [Full Text] [Related]  

  • 5. Efalizumab-induced inflammatory polyarthritis: what are the implications?
    Lyman J; Serebro L
    South Med J; 2010 Apr; 103(4):357-60. PubMed ID: 20224509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbation of psoriatic skin lesions in a patient with psoriatic arthritis receiving adalimumab.
    Borrás-Blasco J; Gracia-Perez A; Nuñez-Cornejo C; Rosique-Robles JD; Mateu-Puchades A; Casterá MD; Rubio-Fabra M
    J Clin Pharm Ther; 2008 Jun; 33(3):321-5. PubMed ID: 18452420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psoriasis and psoriatic arthritis induced by nivolumab (Opdivo
    Schmutz JL
    Ann Dermatol Venereol; 2016 Dec; 143(12):881-882. PubMed ID: 27692689
    [No Abstract]   [Full Text] [Related]  

  • 8. Arthralgia as an adverse event to infliximab: a reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept.
    Moustou AE; Stratigos AJ; Vergou T; Gregoriou S; Georgala S; Danopoulou I
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):968-9. PubMed ID: 19207660
    [No Abstract]   [Full Text] [Related]  

  • 9. De novo onset of arthritis in patients previously treated with efalizumab: an observational case series.
    Colina M; Cianco G; Khodeir M; Sferra S; Scanavacca P; Corazza M; Virgili A; Trotta F
    Clin Exp Rheumatol; 2011; 29(1):141. PubMed ID: 21345301
    [No Abstract]   [Full Text] [Related]  

  • 10. Psoriasis and psoriatic arthritis induced in a patient treated with infliximab for Crohn's disease.
    Tichy M; Tichy M; Kopova R; Sternbersky J; Ditrichova D
    J Dermatolog Treat; 2012 Jun; 23(3):208-11. PubMed ID: 21254868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: a 'class effect' of TNF-alpha antagonists or simply an anti-psoriatic treatment adverse reaction?
    Rallis E; Korfitis C; Stavropoulou E; Papaconstantis M
    J Dermatolog Treat; 2010 Jan; 21(1):3-5. PubMed ID: 19701844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory arthritis following ustekinumab treatment for psoriasis: a report of two cases.
    de Souza A; Ali-Shaw T; Reddy SM; Fiorentino D; Strober BE
    Br J Dermatol; 2013 Jan; 168(1):210-2. PubMed ID: 23278559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis and psoriatic arthritis induced by nivolumab in a patient with advanced lung cancer.
    Law-Ping-Man S; Martin A; Briens E; Tisseau L; Safa G
    Rheumatology (Oxford); 2016 Nov; 55(11):2087-2089. PubMed ID: 27436004
    [No Abstract]   [Full Text] [Related]  

  • 14. Ustekinumab for psoriasis and psoriatic arthritis.
    Goldminz AM; Gottlieb AB
    J Rheumatol Suppl; 2012 Jul; 89():86-9. PubMed ID: 22751602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab in psoriasis and psoriatic arthritis.
    Papoutsaki M; Osório F; Morais P; Torres T; Magina S; Chimenti S; Costanzo A
    BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma.
    Mielke F; Schneider-Obermeyer J; Dörner T
    Ann Rheum Dis; 2008 Jul; 67(7):1056-7. PubMed ID: 18556453
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective new biologic therapies for psoriasis and psoriatic arthritis.
    Mortel MR; Emer J
    J Drugs Dermatol; 2010 Aug; 9(8):947-58. PubMed ID: 20684145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When there is no single best biological agent: psoriasis and psoriatic arthritis in the same patient responding to two different biological agents.
    Adişen E; Karaca F; Gürer MA
    Clin Exp Dermatol; 2008 Mar; 33(2):164-6. PubMed ID: 18257837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteomyelitis occurring during infliximab treatment of severe psoriasis.
    Sri JC; Tsai CL; Deng A; Gaspari AA
    J Drugs Dermatol; 2007 Feb; 6(2):207-10. PubMed ID: 17373180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series.
    Lowes MA; Turton JA; Krueger JG; Barnetson RS
    BMC Dermatol; 2005 Aug; 5():9. PubMed ID: 16109173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.